Achour A, Moukrim Z, Picard O, Bizzini B, Burny A, Zagury D
Université Pierre et Marie Curie, Paris, France.
Cell Mol Biol (Noisy-le-grand). 1995 May;41(3):395-400.
In an attempt to determine whether immunization of healthy HIV-1 seronegative individuals with a soluble gp160 candidate vaccine could induce an anti-HIV specific immune response, volunteers were immunized by two injections of a water-in-oil emulsion containing a mixture of gp160 antigen together with selected peptides. Following immunization, lymphocytes were collected and stimulated in vitro with autologous HIV-1-infected cells. The results showed that immunization with soluble HIV-1 envelope was able to generate CD3+ CD8+ CTLs directed to gp160 antigen. The CTL response was restricted to class I molecule HLA-A2. The CTL response was comparable to that elicited by immunization with HIV-1-envelope recombinant vaccinia virus.
为了确定用可溶性gp160候选疫苗对健康的HIV-1血清阴性个体进行免疫是否能诱导抗HIV特异性免疫反应,志愿者通过两次注射含有gp160抗原与选定肽混合物的油包水乳剂进行免疫。免疫后,收集淋巴细胞并用自体HIV-1感染细胞在体外进行刺激。结果表明,用可溶性HIV-1包膜进行免疫能够产生针对gp160抗原的CD3+ CD8+ CTL。CTL反应限于I类分子HLA-A2。CTL反应与用HIV-1包膜重组痘苗病毒免疫所引发的反应相当。